Specifically, we demonstrated that MAP2K4 was the therapeutic target of the small compound, 4′,5,7-trihydroxyisoflavone (genistein), for its effects upon invasion inhibition [11], [12], and that genistein inhibits human PCa metastasis in an orthotopic murine model [13]. This evidence concerns the gene MAP2K4 and posterior cortical atrophy.